Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue, net	$ 8,248	$ 7,725	$ 22,752	$ 20,005
Cost of revenue (excluding amortization of $1,115 and $1,079, for the three months and $3,346 and $2,874 for the nine months, respectively)	5,194	4,835	15,156	10,489
Gross profit	3,054	2,890	7,596	9,516
Operating expenses:
Sales and marketing	2,699	2,757	6,776	8,127
Research and development	763	857	2,123	2,032
General and administrative	4,482	4,492	13,481	9,613
Acquisition related expense		838		2,534
Acquisition related amortization expense	1,115	1,079	3,346	2,874
Total operating expenses	9,059	10,023	25,726	25,180
Operating loss	(6,005)	(7,133)	(18,130)	(15,664)
Interest accretion	(138)	(111)	(414)	(331)
Other (expense) income, net	(12)	(135)	473	(12)
Loss from continuing operations before tax	(6,155)	(7,379)	(18,071)	(16,007)
Provision for income taxes	14	9	43	19
Loss from continuing operations, net of tax	(6,169)	(7,388)	(18,114)	(16,026)
Loss from discontinued operations, net of tax	(65)	(58)	(194)	(51)
Net loss	(6,234)	(7,446)	(18,308)	(16,077)
Less adjustment for preferred stock deemed dividend			(3,033)
Less dividends on preferred stock		(75)		(75)
Net loss attributable to common stockholders	$ (6,234)	$ (7,521)	$ (21,341)	$ (16,152)
Basic and diluted loss per share of common stock:
From continuing operations	$ (1.53)	$ (1.95)	$ (5.25)	$ (4.34)
From discontinued operations	(0.01)	(0.02)	(0.05)	(0.01)
Net loss per basic and diluted share of common stock	$ (1.54)	$ (1.97)	$ (5.30)	$ (4.35)
Weighted average number of common shares and common share equivalents outstanding:
Basic	4,038	3,820	4,025	3,717
Diluted	4,038	3,820	4,025	3,717